ALIVUS
Alivus Life Sciences Limited
Pharmaceuticals
Share price
₹1,351
Market cap
₹16,557 Cr
1Y return
▲ 40%
A specialized pharmaceutical manufacturer focused on developing and producing high-value active pharmaceutical ingredients for chronic disease treatments across multiple therapeutic areas. Operating as a subsidiary of Nirma Limited, a diversified conglomerate, the company serves global specialty pharmaceutical companies through contract development and manufacturing services. Its distinctive strength lies in producing non-commoditized APIs where technical expertise, regulatory compliance, and quality standards are paramount.
Investors holding Alivus Life Sciences Limited
2.51%
Latest move
ICICI Prudential Mutual FundExited
ICICI Prudential Mutual Fund, which previously held a 1.28 percent stake in Alivus Life Sciences Limited, is no longer listed among the company's disclosed shareholders, indicating either a complete sale or a reduction to below the 1 percent reporting threshold.
Sign in to read more
Whales made 1 more move in Alivus Life Sciences Limited
Sign in to see who is buying and selling.
Sign in to find out